Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-06

FDA Approved: DARIFENACIN — Original Application (POLYGEN PHARMACEUTICALS INC.)

View source ↗

Summary

The FDA approved the original generic application for darifenacin hydrobromide, a generic version of darifenacin for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darifenacin hydrobromide (Darifenacin hydrobromide)

Snippet

ORIG AP for DARIFENACIN (DARIFENACIN HYDROBROMIDE)